Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients

AIDS Research and Human Retroviruses

Volumn 22, Issue 12, 2006, Pages 1248-1252

  Garcia, Rosa ^a   Badaró, Roberto ^a,b   Netto, Eduardo M ^a   Silva, Marcio ^a   Amorin, Fabio S ^a   Ramos, Andre ^a   Vaida, Florin ^c   Brites, Carlos ^a   Schooley, Robert T ^c,d  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b AIDS Reference Center (CREAIDS)   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Stein Clinical Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; BRAZIL; DRUG TREATMENT FAILURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MEDICATION ADHERENCE QUESTIONNAIRE; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; VIRUS LOAD;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; TREATMENT FAILURE; TREATMENT REFUSAL; VIRAL LOAD;

EID: 33846254590     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.1248     Document Type: Article

References (26)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Garcia R, Schooley RT, and Badaro R: An adherence trilogy is essential for long-term HAART success. Braz J Infect Dis 2003;7:307-314.
3. Paterson DL, Swindells S, Mohr J, et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
4. Arnsten JH, Demas PA, Farzadegan H, et al.: Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clin Infect Dis 2001;33:1417-1423.
5. Duong M, Piroth L, Grappin M, et al.: Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens. HIV Clin Trials 2001;2:128-135.
6. Duong M, Golzi A, Peytavin G, et al.: Usefulness of therapeutic drug monitoring of antiretrovirals in routine clinical practice. HIV Clin Trials 2004;5:216-223.
7. Rabkin JG and Chesney MA: Adhering to complex regimens for HIV. GMHC Treat Issues 1998;12:8-11.
8. Smith SR, Rublein JC, Marcus C, Brock TP, and Chesney MA: A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns 2003;50:187-199.
9. Duong M, Piroth L, Peytavin G, et al.: Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response. Clin Infect Dis 2001;33:386-392.
10. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, and Bozzette SA: Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-395.
11. Chesney MA, Ickovics JR, Chambers DB, et al.: Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-266.
12. Loo VS, Diaz T, Gadelha AM, et al.: Managing HIV-infected patients on antiretroviral therapy in Rio de Janeiro, Brazil: Do providers follow national guidelines? AIDS Care 2004;16:834-840.
13. Spire B, Duran S, Souville M, Leport C, Raffi F, and Moatti JP: Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Soc Sci Med 2002;54:1481-1496.
14. Chesney MA: Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30(Suppl. 2):S171-S176.
15. Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, and Saag MS: Patient-perceived barriers to antiretroviral adherence: Associations with race. AIDS Care 2002;14:607-617.
16. Nemes MIB, Carvalho HB, and Souza MFM: Antiretroviral therapy adherence in Brazil. AIDS 2004;18:S15-20.
17. Catz SL, Gore-Felton C, and McClure JB: Psychological distress among minority and low-income women living with HIV. Behav Med 2002;28:53-60.
18. Moatti JP, Spire B, and Duran S: [A review of socio-behavioural studies on adherence to antiretroviral treatments: Beyond biomedical models?]. Rev Epidemiol Sante Publique 2000;48:182-197.
19. Reynolds NR, Testa MA, Marc LG, et al.: Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004;8:141-150.
20. Weiser S, Wolfe W, Bangsberg D, et al.: Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003;34:281-288.
21. Laniece I, Ciss M, Desclaux A, et al.: Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003;17(Suppl. 3):S103-S108.
22. Kirkland LR, Fischl MA, Tashima KT, et al.: Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment. Clin Infect Dis 2002;34:511-518.
23. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, and Karstaedt AS: Adherence to antiretroviral therapy in HIV-1 infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004;20:1053-1056.
24. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, and Bozzette SA: Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-395.
25. Stout BD, Paz Leon M, and Niccolai LM: Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDS 2004;18:297-304.
26. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall DN, et al.: The value of patient reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999;13:1099-1107.